3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
16
Terminated
4
Active not recruiting
3
Withdrawn
1
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Hematologic Neoplasms
5
Myelodysplastic Syndromes
4
Tuberous Sclerosis
2
Recurrence
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Epilepsy
2
Bronchiolitis Obliterans Syndrome
2
Thyroid Neoplasms
1
Solid Tumor
1
Sarcoma
1
Prostate Cancer Recurrent
1
Non-Malignant Neoplasm
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma
1
Lymphangioleiomyomatosis
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Interventions
Cyclophosphamide
10
fludarabine
6
Tacrolimus
5
Mycophenolic Acid
5
Melphalan
4
ruxolitinib
3
Whole-Body Irradiation
3
Thiotepa
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Stem Cell Transplantation
2
Specimen Handling
2
Clofarabine
2
Biopsy
2
vedolizumab
1
belumosudil
1
Tomography, Optical Coherence
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Prednisone
1
Methotrexate
1
Mesna
1
Low-Level Light Therapy
1
LDP-02
1
Immunoglobulin G
1
Hematopoietic Stem Cell Transplantation
1
Fecal Microbiota Transplantation
1
Emapalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Graft vs Host Disease
×
Sirolimus
×
Clear all
NCT06799195
2025-12-15
PTCYGVHD
University of Nebraska
Phase 2
Recruiting
126 enrolled